Okaya, Japan

Hiroshi Matsukubo

This inventor holds 5 USPTO granted patents. Top assignee: Kyorin Pharmaceutical Co., Ltd.. Active years: 1988-1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroshi Matsukubo. Retrieved from https://idiyas.com/inventor/hiroshi-matsukubo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.1

ph-index = 2

Forward Citations = 39(Granted Patents)


Company Filing History:


Years Active: 1988-1992

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Hiroshi Matsukubo: Innovator in Pharmaceutical Compounds

Introduction

Hiroshi Matsukubo is a notable inventor based in Okaya, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds. With a total of 5 patents to his name, Matsukubo's work has had a meaningful impact on medicinal chemistry.

Latest Patents

Matsukubo's latest patents include innovative compounds such as (6,7)-substituted-8-alkoxy-1-cyclopropyl-1,4-dihydro. This invention relates to novel compounds that serve as intermediates in the preparation of quinoline carboxylic acid medicaments. Another significant patent involves urea derivatives, which are useful antiulcer agents. These derivatives feature complex structures that include various functional groups, enhancing their therapeutic potential.

Career Highlights

Hiroshi Matsukubo is currently associated with Kyorin Pharmaceutical Co., Ltd., where he continues to advance his research in pharmaceutical compounds. His work has been instrumental in developing new medications that address various health issues.

Collaborations

Matsukubo has collaborated with esteemed colleagues such as Kyuya Okamura and Kuniyoshi Masuzawa. These partnerships have fostered a collaborative environment that enhances innovation and research in their field.

Conclusion

Hiroshi Matsukubo's contributions to pharmaceutical innovations exemplify the importance of research and development in medicine. His patents reflect a commitment to improving health outcomes through novel chemical compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…